EUVIMEDEUVIMED entdecken
Crossref

New Robust Synthetic Strategy toward the Radiopharmaceutical Labeling Precursor FAPI-46

Zhipeng Lu, Yan Hu, Benqin Xu, Chenhao Liao, Jialin Sun, Tingyou Li, Panpan Chen

Organic Process Research & Development · 19.12.2025 · 29 (12) · 3138-3149

DOI: 10.1021/acs.oprd.5c00267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 18.11.2025. Verfasst von Zhipeng Lu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Nanjing Medical University, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The radiolabeled FAPI-46 has been extensively employed as a diagnostic and therapeutic agent for malignancies. Based on our endeavor to reproduce the synthetic route of FAPI-46, we systematically elucidate the practical challenges encountered. Then, our effort in optimizing the synthetic route of FAPI-46 characterized by practicality, cost-effectiveness, and high reproducibility was presented here. Initially, we have explored four routes for synthesizing the key intermediate 19, among which the one that obtained 24 via the Pd 2 (dba) 3 -catalyzed C–N coupling between methyl quinoline-4-carboxylate 20 and silyl-protected 3-hydroxypropylamine 23, followed by desilylation and sulfonylation of the hydroxyl group of 24, proved to be the optimal route to obtain 19 . Subsequently, the condensation of lithium quinoline-4-carboxylate 34 with nitrile-pyrrole-substituted amine 8 using N,N,N′N ′ -tetramethylchloroformamidinium hexafluorophosphate (TCFH) as the condensing agent to afford 9 demonstrated a notably streamlined process and satisfactory yield. This feasible and robust strategy offered a valuable procedure for the large-scale production of FAPI-46 and its analogues containing the quinoline-4-carboxylic acid scaffold.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Nanjing Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Lu, Z., Hu, Y., Xu, B., Liao, C., Sun, J., Li, T., & Chen, P. (2025). New Robust Synthetic Strategy toward the Radiopharmaceutical Labeling Precursor FAPI-46. Organic Process Research & Development, 29(12), 3138-3149. https://doi.org/10.1021/acs.oprd.5c00267

Vancouver

Lu Z, Hu Y, Xu B, Liao C, Sun J, Li T, et al. New Robust Synthetic Strategy toward the Radiopharmaceutical Labeling Precursor FAPI-46. Organic Process Research & Development. 2025;29(12):3138-3149. doi:10.1021/acs.oprd.5c00267

BibTeX
@article{Lu2025,
  author = {Lu, Zhipeng and Hu, Yan and Xu, Benqin and Liao, Chenhao and Sun, Jialin and Li, Tingyou and Chen, Panpan},
  title = {New Robust Synthetic Strategy toward the Radiopharmaceutical Labeling Precursor FAPI-46},
  journal = {Organic Process Research & Development},
  year = {2025},
  volume = {29},
  number = {12},
  pages = {3138--3149},
  doi = {10.1021/acs.oprd.5c00267}
}
Kostenlos starten →